Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN1C anticorps

L’anticorps Souris Monoclonal anti-CDKN1C a été validé pour IHC (f). Il convient pour détecter CDKN1C dans des échantillons de Humain.
N° du produit ABIN6939049

Aperçu rapide pour CDKN1C anticorps (ABIN6939049)

Antigène

Voir toutes CDKN1C Anticorps
CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Reactivité

  • 95
  • 57
  • 25
  • 2
  • 1
Humain

Hôte

  • 65
  • 32
Souris

Clonalité

  • 61
  • 36
Monoclonal

Conjugué

  • 53
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CDKN1C est non-conjugé

Application

  • 43
  • 38
  • 34
  • 32
  • 21
  • 15
  • 14
  • 14
  • 8
  • 7
  • 4
  • 3
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

KP10
  • Specificité

    Recognizes a protein of 57 kDa, identified as p57Kip2. It shows no cross-reaction with p27Kip1. p57Kip2 is a potent tight-binding inhibitor of several G1 cyclin complexes, and is a negative regulator of cell proliferation. Anti-p57 has been used as an aide in identification of complete hydatidiform mole (CHM) (no nuclear labeling of cytotrophoblasts and stromal cells) from partial hydatidiform mole (PHM) in which both cytotrophoblasts and stromal cells stain. The histological differentiation of complete mole, partial mole, and hydropic spontaneous abortion is problematic. Most complete hydatidiform moles are diploid, whereas most partial moles are triploid. Ploidy studies will identify partial moles, but will not differentiate complete moles from non-molar gestations. Complete moles carry a high risk of persistent disease and choriocarcinoma, while partial moles have a very low risk. In normal placenta, many cytotrophoblast nuclei and stromal cells are labeled with this antibody. Similar findings apply to PHM and hydropic abortus tissues. Intervillous trophoblastic islands (IVTIs) demonstrate nuclear labeling in all three entities and serve as an internal control.

    Réactivité croisée (Details)

    Human, Mouse,

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant human p57Kip2 protein

    Isotype

    IgG2b
  • Indications d'application

    Positive Control: LS174T, Raji, HT29, SK-BR3 cells. Colon or Prostate carcinomas.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.

    Date de péremption

    24 months
  • Antigène

    CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

    Autre désignation

    CDKN1C

    Sujet

    Beckwith Wiedemann syndrome (WBS), BWCR, Cyclin dependent kinase inhibitor 1C (CDKN1C), Cyclin dependent kinase inhibitor p57, KIP2, p57, p57Kip2,p57Kip2 (Mitotic Inhibitor/Suppressor Protein)
    Cellular localisation: Nuclear

    Poids moléculaire

    57kDa

    ID gène

    1028, 106070

    UniProt

    P49918

    Pathways

    Cycle Cellulaire, Dopaminergic Neurogenesis
Vous êtes ici:
Chat with us!